Return to Publications
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.

Return to Publications  |  Return to CINJ Home
The Cancer Institute of New Jersey's Cancer Connection, March 2012

Your link to the latest news on research, treatment, prevention and education from the state's only

National Cancer Institute-designated Comprehensive Cancer Center



Meridian Health Partners with CINJ on Colorectal Cancer Study


colorectal cancer study

The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment. The death rate from colorectal cancer has been on the decline for the past 15 years, which means more patients are surviving their disease. But are they surviving it in a way that enhances quality of life and minimizes the risk of cancer recurrence? That is one of the questions researchers hope to answer in an effort to promote positive health behavior changes in this population.Read more

CINJ Celebrates its Social Workers During National Social Work Month


CINJ Social Work team

At The Cancer Institute of New Jersey, oncology social workers tend to the psychosocial needs of cancer patients and their families through such support services as educational groups, individual and family counseling, and referrals. They also provide important information on stress management, decision making, advance directives, and cost and availability of services. Throughout the month of March, CINJ will join in recognizing that "Social Work Matters," the theme for this year's National Professional Social Work Month. Learn more about CINJ's social work services.

Healthy Male Volunteers Needed for Selenium Study


selenium study

CINJ researchers are studying the effects of the mineral selenium in reducing one's risk for prostate cancer. At focus are selenium yeast or selenomethionine and whether they have a role in lowering prostate-specific antigen (PSA) levels and preventing other markers related to the development of prostate cancer in healthy men of different ages. Participants will be asked to take over-the-counter selenium supplements or a placebo for twelve months.Read more

RWJMS logo    CINJ logo        NCI logo 

CINJ Office of Communications  ·  195 Little Albany Street  ·  New Brunswick, NJ  ·  732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List